HELICO

Preparations, namely, compounds produced by stable transgenic plant lines; preparations, namely, biologics, biosimilars, and pharmaceuticals produced by stable transgenic plant lines with therapeutic applications; preparations, namely, chemical compounds, biosurfactants, and lubricants produced by stable transgenic plant lines with industrial applications; preparations, namely, pesticides, fertilizers, and reducers of carbon emissions produced by stable transgenic plant lines with environmental or agrochemical applications; stable transgenic plant lines developed to produce and/or purify molecules of interest; molecular tools for allowing expression of genes and/or molecules in planta; customized plant strains created using molecular tools; customized plant strains engineered to produce specific compounds; customized plant strains engineered to produce small molecules, peptides, or proteins that can be used for medical or veterinary purposes; plant development platform for producing genetically modified platforms that have been engineered to create specific compounds; therapeutic molecules for medical or veterinary preparations; pharmaceuticals

Biotechnology research; biotechnology services, namely, research and development in the area of transgenic plant lines; research and development in relation to compound production; research and development in relation to transgenic plant lines; research and development in relation to the engineering of transgenic plant lines customized to produce compounds; product development services for others in the area of biotechnology for research, clinical, therapeutic, and manufacturing purposes; compound production services for scientific, research, clinical, therapeutic, and manufacturing purposes; consultancy relating to compound production; laboratory research in the fields of engineered plant strains, compound production, and molecular purification; development of software-implemented algorithms for biotechnology and chemistry purposes; development of software-implemented algorithms for molecular visualization; development of software-implemented algorithms for predicting biological, chemical, and molecular interactions; development of software-implemented databases containing information regarding molecular functions and interactions; research services for medical purposes; consultancy services in relation to biotechnology research, development, and production; consultancy services in relation to modeling of molecular interactions; consultancy services in relation to creating customized plant varieties

Preparation of compounds with therapeutic applications; preparations for treating medical conditions, namely, biologics, biosimilars, and pharmaceuticals produced by stable transgenic plant lines; production of therapeutic compounds using stable transgenic plant lines; providing a database with information regarding plant strains engineered to produce compounds with therapeutic applications; providing a database with information regarding chemo-informatic tools that allow biological, chemical, and molecular interactions to be predicted; plant engineering services; services related to the development of transgenic plant lines; medical services, namely, providing therapies for treating ailments; veterinary services, namely, providing therapies for treating ailments; consultation services related to the research, development, and production of compounds with therapeutic applications; preparation of compounds with agricultural applications